Transcranial Magnetic Stimulation (TMS) is one of the fastest growing treatments for treatment-resistant depression (TRD). TMS is a proven safe and effective non-invasive treatment that can be offered as an additional service within an established practice, or in a dedicated TMS clinic. Read More about TMS.
What is TMS?
TMS Market Worldwide
According to Business Wire, the Transcranial Magnetic Stimulator (TMS) Market is expected to grow at a CAGR of 8.8% from 2021 to 2028.
BrainsWay Ltd, Nexstim, Magstim, Neuronetics, TMS Neuro Solutions, MagVenture, Inc., eNeura Inc., Neurosoft, MAG & More GmbH. are among the leading companies operating in the Transcranial Magnetic Stimulator (TMS) market.
TMS In South Africa
TMS is relatively new in South Africa. As such the market is wide open, but it does have unique challenges.
The big problem with TMS in South Africa is that it healthfunders are not paying for it (yet), thus it remains unaffordable for a large part of the population.
SASOP (South African Society of Psychiatrists)is currently (2021) defining new treatment guidelines, including TMS for TRD. With this we can begin pressuring funders to cover for TMS.
